Table 2.
Most commonly discussed symptoms in the overall population and by disease stage
| Symptom | Total (N = 30) | NDMM (n = 18) | RRMM (n = 12) |
|---|---|---|---|
| Bone pain | 27 (90.0) | 17 (94.0) | 10 (83.0) |
| Fatigue/tiredness | 26 (87.0) | 16 (89.0) | 10 (83.0) |
| Tingling hands or feet or restless leg | 9 (30.0) | 5 (28.0) | 4 (33.0) |
| Infection | 8 (27.0) | 4 (22.0) | 4 (33.0) |
| Sleepiness | 4 (13.0) | 2 (11.0) | 2 (17.0) |
| Constipation | 4 (13.0) | 3 (17.0) | 1 (8.0) |
| Muscle cramps | 3 (10.0) | 2 (11.0) | 1 (8.0) |
| Headache | 3 (10.0) | 0 | 3 (25.0) |
| Insomnia | 3 (10.0) | 3 (17.0) | 0 |
Data are presented as n (%). Symptoms discussed in more than one interview; includes both spontaneous and prompted mentions; one or more “other” symptoms (including anemia, bleeding, circulatory issues, cognitive issues, depression, diarrhea, dizziness, fainting, hair loss, heartburn, joint pain, lack of motivation, nausea, night sweats, nosebleeds, one-sided weakness, osteoporosis, other bone [e.g., dissolution, fracture], popliteal cyst, shortness of breath, sweating, tinnitus, weakness, uncertainty on feet, vision problems, vomiting, and weight loss) were mentioned in 15 (50.0%) interviews
NDMM newly diagnosed multiple myeloma, RRMM relapsed/refractory multiple myeloma